Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors
2012 ◽
Vol 18
(17)
◽
pp. 4794-4805
◽
2008 ◽
Vol 6
(12)
◽
pp. 69
◽